Real-Life Experience of a Brief Arsenic Trioxide-Based Consolidation Chemotherapy in the Management of Acute Promyelocytic Leukemia: Favorable Outcomes With Limited Anthracycline Exposure and Shorter Consolidation Therapy

Arsenic trioxide (ATO)-based consolidation chemotherapy can be effective in patients with high-risk acute promyelocytic leukemia (APL) and might reduce anthracycline-related toxicity. We report a retrospective analysis of 63 patients with APL given 1 cycle of ATO-based consolidation chemotherapy. Th...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Lymphoma Myeloma Leuk
Glavni autori: Leech, Mindy, Morris, Lawrence, Stewart, Moishe, Smith, B. Douglas, Bashey, Asad, Holland, Kent, Solomon, Scott, Zhang, Xu, Carraway, Hetty E., Pratz, Keith, Gore, Steven D., Zeidan, Amer M.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4409502/
https://ncbi.nlm.nih.gov/pubmed/25499624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2014.11.001
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items